Anika Therapeutics | ANIK - Ebitda





Ebitda Alterar Data
Abbott USD 3.27B 178M 2025-12
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -148.3M 165.88M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intrexon USD -24.7M 2.92M 2024-06
J&J USD 7.19B 2.32B 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
MacroGenics USD 21.95M 55.39M 2025-09
Merit Medical Systems USD 97.23M 17.69M 2025-12
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Sanofi EUR 3.31B 3.65B 2026-03
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.57B 618M 2026-03
Surmodics USD 3.43M 1.9M 2025-06
Veracyte USD 42.8M 488K 2026-03
Xencor USD -51.05M 55.28M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12